Literature DB >> 33672652

Synthesis, Neuroprotection, and Antioxidant Activity of 1,1'-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models.

Beatriz Chamorro1,2,3, David García-Vieira2, Daniel Diez-Iriepa2,4, Estíbaliz Garagarza1, Mourad Chioua2, Dimitra Hadjipavlou-Litina5, Francisco López-Muñoz3,6, José Marco-Contelles2, María Jesús Oset-Gasque1,7.   

Abstract

Herein, we report the neuroprotective and antioxidant activity of 1,1'-biphenyl nitrones (BPNs) 1-5 as α-phenyl-N-tert-butylnitrone analogues prepared from commercially available [1,1'-biphenyl]-4-carbaldehyde and [1,1'-biphenyl]-4,4'-dicarbaldehyde. The neuroprotection of BPNs1-5 has been measured against oligomycin A/rotenone and in an oxygen-glucose deprivation in vitro ischemia model in human neuroblastoma SH-SY5Y cells. Our results indicate that BPNs 1-5 have better neuroprotective and antioxidant properties than α-phenyl-N-tert-butylnitrone (PBN), and they are quite similar to N-acetyl-L-cysteine (NAC), which is a well-known antioxidant agent. Among the nitrones studied, homo-bis-nitrone BPHBN5, bearing two N-tert-Bu radicals at the nitrone motif, has the best neuroprotective capacity (EC50 = 13.16 ± 1.65 and 25.5 ± 3.93 μM, against the reduction in metabolic activity induced by respiratory chain blockers and oxygen-glucose deprivation in an in vitro ischemia model, respectively) as well as anti-necrotic, anti-apoptotic, and antioxidant activities (EC50 = 11.2 ± 3.94 μM), which were measured by its capacity to reduce superoxide production in human neuroblastoma SH-SY5Y cell cultures, followed by mononitrone BPMN3, with one N-Bn radical, and BPMN2, with only one N-tert-Bu substituent. The antioxidant activity of BPNs1-5 has also been analyzed for their capacity to scavenge hydroxyl free radicals (82% at 100 μM), lipoxygenase inhibition, and the inhibition of lipid peroxidation (68% at 100 μM). Results showed that although the number of nitrone groups improves the neuroprotection profile of these BPNs, the final effect is also dependent on the substitutent that is being incorporated. Thus, BPNs bearing N-tert-Bu and N-Bn groups show better neuroprotective and antioxidant properties than those substituted with Me. All these results led us to propose homo-bis-nitrone BPHBN5 as the most balanced and interesting nitrone based on its neuroprotective capacity in different neuronal models of oxidative stress and in vitro ischemia as well as its antioxidant activity.

Entities:  

Keywords:  1,1′-biphenyl nitrones; antioxidants; free radical scavengers; neuroprotection; oligomycin A/rotenone; oxygen-glucose-deprivation; synthesis; α-phenyl-N-tert-butylnitrone

Mesh:

Substances:

Year:  2021        PMID: 33672652      PMCID: PMC7926640          DOI: 10.3390/molecules26041127

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  28 in total

1.  De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.

Authors:  Paul A Lapchak; David R Schubert; Pamela A Maher
Journal:  Transl Stroke Res       Date:  2011-06       Impact factor: 6.829

2.  Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia.

Authors:  Maria I Ayuso; Emma Martínez-Alonso; Mourad Chioua; Alejandro Escobar-Peso; Rafael Gonzalo-Gobernado; Joan Montaner; José Marco-Contelles; Alberto Alcázar
Journal:  ACS Chem Neurosci       Date:  2017-08-09       Impact factor: 4.418

Review 3.  Oxidative stress in Parkinson's disease.

Authors:  Peter Jenner
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

4.  Asymmetric "Acetylenic" [3+2] Cycloaddition of Nitrones Catalyzed by Cationic Chiral PdII Lewis Acid.

Authors:  Kazuya Honda; Koichi Mikami
Journal:  Chem Asian J       Date:  2018-08-29

5.  Effect of radical scavenger N-tert-butyl-alpha-phenylnitrone on stroke in a rat model using a telemetric system.

Authors:  Kieko Saito; Chinatsu Kobayashi; Masahiko Ikeda
Journal:  J Pharm Pharm Sci       Date:  2008       Impact factor: 2.327

6.  NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.

Authors:  Hans-Christoph Diener; Kennedy R Lees; Patrick Lyden; Jim Grotta; Antoni Davalos; Stephen M Davis; Ashfaq Shuaib; Tim Ashwood; Warren Wasiewski; Vivian Alderfer; Hans-Goran Hårdemark; Larry Rodichok
Journal:  Stroke       Date:  2008-03-27       Impact factor: 7.914

7.  A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-κB and the PKCα/PI3-K/Akt pathways.

Authors:  Da-Ping Xu; Kun Zhang; Zai-Jun Zhang; Ye-Wei Sun; Bao-Jian Guo; Yu-Qiang Wang; Pui-Man Hoi; Yi-Fan Han; Simon Ming-Yuen Lee
Journal:  Neurochem Int       Date:  2014-09-10       Impact factor: 3.921

8.  Phenyl-T-butyl-nitrone is active against traumatic shock in rats.

Authors:  G P Novelli; P Angiolini; R Tani; G Consales; L Bordi
Journal:  Free Radic Res Commun       Date:  1986

9.  Novel cinnamic acid derivatives as antioxidant and anticancer agents: design, synthesis and modeling studies.

Authors:  Eleni Pontiki; Dimitra Hadjipavlou-Litina; Konstantinos Litinas; George Geromichalos
Journal:  Molecules       Date:  2014-07-07       Impact factor: 4.411

10.  Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models.

Authors:  Beatriz Chamorro; Daniel Diez-Iriepa; Belén Merás-Sáiz; Mourad Chioua; David García-Vieira; Isabel Iriepa; Dimitra Hadjipavlou-Litina; Francisco López-Muñoz; Ricardo Martínez-Murillo; Daniel Gonzàlez-Nieto; Israel Fernández; José Marco-Contelles; María Jesús Oset-Gasque
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

View more
  1 in total

1.  Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities.

Authors:  Yingda Zang; Ke Liu; Weiping Wang; Chuangjun Li; Jie Ma; Jingzhi Yang; Xinyi Chen; Xiaoliang Wang; Dongming Zhang
Journal:  Molecules       Date:  2021-02-28       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.